Research and Markets: Germ Cell Tumors - Pipeline Review, H2 2013
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2m8zhh/germ_cell_tumors) has announced the addition of the "Germ Cell Tumors - Pipeline Review, H2 2013" report to their offering.
“Germ Cell Tumors - Pipeline Review, H2 2013”
'Germ Cell Tumors - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Germ Cell Tumors, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Germ Cell Tumors.
- A snapshot of the global therapeutic scenario for Germ Cell Tumors.
- A review of the Germ Cell Tumors products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Germ Cell Tumors pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Key Topics Covered:
Germ Cell Tumors Overview
Pipeline Products for Germ Cell Tumors - Overview
Pipeline Products for Germ Cell Tumors - Comparative Analysis
Germ Cell Tumors - Therapeutics under Development by Companies
Germ Cell Tumors - Therapeutics under Investigation by Universities/Institutes
Germ Cell Tumors - Pipeline Products Glance
Clinical Stage Products
Early Stage Products
Germ Cell Tumors - Products under Development by Companies
Germ Cell Tumors - Products under Investigation by Universities/Institutes
Germ Cell Tumors - Companies Involved in Therapeutics Development
Germ Cell Tumors - Therapeutics Assessment
alvocidib hydrocholride - Drug Profile
palifosfamide - Drug Profile
tivantinib - Drug Profile
Allogeneic Tumor Cell Vaccine + [celecoxib] + [cyclophosphamide] - Drug Profile
Combretastatin Analogs - Drug Profile
Mechanism of Action
Featured News & Press Releases
ZIOPHARM Oncology, Inc.
Tolero Pharmaceuticals, Inc.
For more information visit http://www.researchandmarkets.com/research/2m8zhh/germ_cell_tumors
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.